Simbarashe Rusakaniko1, Elopy Nemele Sibanda2,3, Takafira Mduluza4, Paradzayi Tagwireyi5, Zephaniah Dhlamini3, Chiratidzo Ellen Ndhlovu1, Precious Chandiwana1, Shingirai Chiwambutsa1, Rivka May Lim6,7, Fiona Scott6,7, Lindiwe Majele Sibanda8, Francisca Mutapi6,7. 1. Faculty of Medicine and Health Sciences, University of Zimbabwe, Avondale, Harare, Zimbabwe of Zimbabwe. 2. Asthma Allergy and Immunology Clinic, Twin Palms Medical Centre, Harare, Zimbabwe. 3. Department of Pathology, National University of Science and Technology Medical School, Bulawayo, Zimbabwe. 4. Department of Biotechnology and Biochemistry, University of Zimbabwe, Mount Pleasant, Harare, Zimbabwe. 5. Department of Geography and Environmental Science, Geo-information and Earth Observation Centre, University of Zimbabwe, Mount Pleasant, Harare, Zimbabwe. 6. Institute of Immunology & Infection Research, University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom. 7. NIHR Global Health Research Unit Tackling Infections to Benefit Africa (TIBA), University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom. 8. Iam4BYO-Fighting COVID-19, Castell Court, Bulawayo, Zimbabwe.
Abstract
BACKGROUND: In order to protect health workers from SARS-CoV-2, there is need to characterise the different types of patient facing health workers. Our first aim was to determine both the infection status and seroprevalence of SARS-CoV-2 in health workers. Our second aim was to evaluate the occupational and demographic predictors of seropositivity to inform the country's infection prevention and control (IPC) strategy. METHODS AND PRINCIPAL FINDINGS: We invited 713 staff members at 24 out of 35 health facilities in the City of Bulawayo in Zimbabwe. Compliance to testing was defined as the willingness to uptake COVID-19 testing by answering a questionnaire and providing samples for both antibody testing and PCR testing. SARS-COV-2 antibodies were detected using a rapid diagnostic test kit and SAR-COV-2 infection was determined by real-time (RT)-PCR. Of the 713 participants, 635(89%) consented to answering the questionnaire and providing blood sample for antibody testing while 560 (78.5%) agreed to provide nasopharyngeal swabs for the PCR SARS-CoV-2 testing. Of the 635 people (aged 18-73) providing a blood sample 39.1% reported a history of past COVID-19 symptoms while 14.2% reported having current symptoms of COVID-19. The most-prevalent co-morbidity among this group was hypertension (22.0%) followed by asthma (7.0%) and diabetes (6.0%). The SARS-CoV-2 sero-prevalence was 8.9%. Of the 560 participants tested for SARS-CoV-2 infection, 2 participants (0.36%) were positive for SAR-CoV-2 infection by PCR testing. None of the SARS-CoV-2 antibody positive people were positive for SAR-CoV-2 infection by PCR testing. CONCLUSION AND INTERPRETATION: In addition to clinical staff, several patient-facing health workers were characterised within Zimbabwe's health system and the seroprevalence data indicated that previous exposure to SAR-CoV-2 had occurred across the full spectrum of patient-facing staff with nurses and nurse aides having the highest seroprevalence. Our results highlight the need for including the various health workers in IPC strategies in health centres to ensure effective biosecurity and biosafety.
BACKGROUND: In order to protect health workers from SARS-CoV-2, there is need to characterise the different types of patient facing health workers. Our first aim was to determine both the infection status and seroprevalence of SARS-CoV-2 in health workers. Our second aim was to evaluate the occupational and demographic predictors of seropositivity to inform the country's infection prevention and control (IPC) strategy. METHODS AND PRINCIPAL FINDINGS: We invited 713 staff members at 24 out of 35 health facilities in the City of Bulawayo in Zimbabwe. Compliance to testing was defined as the willingness to uptake COVID-19 testing by answering a questionnaire and providing samples for both antibody testing and PCR testing. SARS-COV-2 antibodies were detected using a rapid diagnostic test kit and SAR-COV-2 infection was determined by real-time (RT)-PCR. Of the 713 participants, 635(89%) consented to answering the questionnaire and providing blood sample for antibody testing while 560 (78.5%) agreed to provide nasopharyngeal swabs for the PCR SARS-CoV-2 testing. Of the 635 people (aged 18-73) providing a blood sample 39.1% reported a history of past COVID-19 symptoms while 14.2% reported having current symptoms of COVID-19. The most-prevalent co-morbidity among this group was hypertension (22.0%) followed by asthma (7.0%) and diabetes (6.0%). The SARS-CoV-2 sero-prevalence was 8.9%. Of the 560 participants tested for SARS-CoV-2 infection, 2 participants (0.36%) were positive for SAR-CoV-2 infection by PCR testing. None of the SARS-CoV-2 antibody positive people were positive for SAR-CoV-2 infection by PCR testing. CONCLUSION AND INTERPRETATION: In addition to clinical staff, several patient-facing health workers were characterised within Zimbabwe's health system and the seroprevalence data indicated that previous exposure to SAR-CoV-2 had occurred across the full spectrum of patient-facing staff with nurses and nurse aides having the highest seroprevalence. Our results highlight the need for including the various health workers in IPC strategies in health centres to ensure effective biosecurity and biosafety.
Authors: Khalid Hajissa; Md Asiful Islam; Siti Asma Hassan; Abdul Rahman Zaidah; Nabilah Ismail; Zeehaida Mohamed Journal: Int J Environ Res Public Health Date: 2022-06-14 Impact factor: 4.614
Authors: Anou M Somboro; Yacouba Cissoko; Issiaka Camara; Ousmane Kodio; Mohamed Tolofoudie; Etienne Dembele; Antieme C G Togo; Djibril M Ba; Yeya Dit Sadio Sarro; Bocar Baya; Seydou Samake; Ibrahim B Diallo; Alisha Kumar; Mohamed Traore; Bourahima Kone; Amadou Kone; Bassirou Diarra; Djeneba K Dabitao; Mamadou Wague; Garan Dabo; Seydou Doumbia; Jane L Holl; Robert L Murphy; Souleymane Diallo; Almoustapha I Maiga; Mamoudou Maiga; Sounkalo Dao Journal: Viruses Date: 2022-01-07 Impact factor: 5.048
Authors: Sophie Alice Müller; Rebekah Ruth Wood; Johanna Hanefeld; Charbel El-Bcheraoui Journal: Health Policy Plan Date: 2022-04-13 Impact factor: 3.344